Profiles

Keywords
Last Name
Institution

Connection

John Somberg to Adrenergic beta-Antagonists

This is a "connection" page, showing publications John Somberg has written about Adrenergic beta-Antagonists.

 
Connection Strength
 
 
 
0.509
 
  1. Somberg JC. Clinical therapeutic conference: congestive heart failure therapy. Am J Ther. 2001 Jan-Feb; 8(1):65-72.
    View in: PubMed
    Score: 0.259
  2. Somberg JC. Evidence based or mechanism based therapeutics. Am J Ther. 2009 Jan-Feb; 16(1):1.
    View in: PubMed
    Score: 0.113
  3. Milan DJ, Saul JP, Somberg JC, Molnar J. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60.
    View in: PubMed
    Score: 0.048
  4. Steinberg JS, Katz RJ, Somberg JC, Keefe D, Laddu AR, Burge J. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
    View in: PubMed
    Score: 0.024
  5. Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.024
  6. Somberg J. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48.
    View in: PubMed
    Score: 0.021
  7. Somberg JC. New directions in antiarrhythmic drug therapy. Am J Cardiol. 1984 Aug 13; 54(4):8B-17B.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.